From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/18782050

Download in:

View as

General Info

PMID
18782050